Maria I. Patricio

Robert Robinson Avenue, Oxfordshire
Oxford, ENG OX44HG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectors.

Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectors.

Journal: Molecular therapy. Methods & clinical development
Published: March 17, 2025

Lentiviral vector packaging and producer cell lines yield titers equivalent to the industry-standard four-plasmid process.

Lentiviral vector packaging and producer cell lines yield titers equivalent to the industry-standard four-plasmid process.

Journal: Molecular therapy. Methods & clinical development
Published: February 13, 2024

Erratum: Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues.

Erratum: Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues.

Journal: Molecular therapy. Methods & clinical development
Published: February 27, 2023

Expression of Rab Prenylation Pathway Genes and Relation to Disease Progression in Choroideremia.

Expression of Rab Prenylation Pathway Genes and Relation to Disease Progression in Choroideremia.

Journal: Translational vision science & technology
Published: July 13, 2021

Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination.

Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination.

Journal: Nature communications
Published: July 02, 2021

Analysis of Early Cone Dysfunction in an In Vivo Model of Rod-Cone Dystrophy.

Analysis of Early Cone Dysfunction in an In Vivo Model of Rod-Cone Dystrophy.

Journal: International journal of molecular sciences
Published: August 09, 2020

Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.

Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.

Journal: Human gene therapy
Published: May 13, 2020

Progress in the development of novel therapies for choroideremia.

Progress in the development of novel therapies for choroideremia.

Journal: Expert review of ophthalmology
Published: February 01, 2020

Association of Messenger RNA Level With Phenotype in Patients With Choroideremia: Potential Implications for Gene Therapy Dose.

Association of Messenger RNA Level With Phenotype in Patients With Choroideremia: Potential Implications for Gene Therapy Dose.

Journal: JAMA ophthalmology
Published: December 20, 2019

Inclusion of PF68 Surfactant Improves Stability of rAAV Titer when Passed through a Surgical Device Used in Retinal Gene Therapy.

Inclusion of PF68 Surfactant Improves Stability of rAAV Titer when Passed through a Surgical Device Used in Retinal Gene Therapy.

Journal: Molecular therapy. Methods & clinical development
Published: June 17, 2019

A Quantitative Chloride Channel Conductance Assay for Efficacy Testing of AAV.BEST1.

A Quantitative Chloride Channel Conductance Assay for Efficacy Testing of AAV.BEST1.

Journal: Human gene therapy methods
Published: April 10, 2019

Atypical choroideremia presenting with early-onset macular atrophy.

Atypical choroideremia presenting with early-onset macular atrophy.

Journal: Acta ophthalmologica
Published: November 16, 2018
Showing 1-12 of 24

Last Updated: 09/26/2026